2BBBullish & Bearish
Bausch Health Companies Inc. Common Stock (BHC) trades on NYSE. It operates in the Health Care sector, Drug Manufacturers - Specialty & Generic industry. Its current 2BB score is 41 out of 100.
Bausch Health Companies Inc. is a global, diversified Canadian pharmaceutical company. Its global corporate headquarters are located in Laval, Quebec, Canada, and its U.S. headquarters are in Bridgewater, New Jersey. It develops, manufactures and markets a range of pharmaceutical products in gastroenterology, hepatology, neuroscience, dermatology, dentistry, medical aesthetics, and international pharmaceuticals.
Bausch Health Companies Inc. Common Stock’s current 2BB score is 41 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 23 | Low |
| Momentum | 32 | Weakening |
| Financial strength | 57 | Normal |
| Quality | 100 | Very Strong |
| Risk | 44 | Moderate |
| CEO | Thomas Appio |
| Headquarters | Laval, Quebec, Canada |
| Founded | 1959 |
| Employees | 20.3K |
| 52-week range | $4.33 – $8.68 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-02-16 | — | 1.35 | — | $2.83B |
| 2026-10-27 | — | 1.2861 | — | $2.77B |
| 2026-07-29 | — | 1.0757 | — | $2.71B |
| 2026-04-29 | 0.78 | 0.6944 | $2.52B | $2.43B |